Pediatric-Inspired Regimens in the Treatment of Acute Lymphoblastic Leukemia in Adolescents and Young Adults: A Systematic Review

被引:1
作者
Zeckanovic, Aida [1 ,2 ]
Fuchs, Philipp [1 ,2 ]
Heesen, Philip [3 ]
Bodmer, Nicole [1 ,2 ]
Otth, Maria [1 ,2 ,4 ,5 ]
Scheinemann, Katrin [4 ,5 ,6 ,7 ]
机构
[1] Univ Childrens Hosp Zurich, Dept Oncol, CH-8032 Zurich, Switzerland
[2] Univ Childrens Hosp Zurich, Childrens Res Ctr, CH-8032 Zurich, Switzerland
[3] Univ Zurich, Fac Med, CH-8006 Zurich, Switzerland
[4] Childrens Hosp Eastern Switzerland, Div Hematol Oncol, CH-9006 St Gallen, Switzerland
[5] Univ Lucerne, Fac Hlth Sci & Med, CH-6000 Luzern, Switzerland
[6] McMaster Childrens Hosp, Dept Pediat, Hamilton, ON L8S 4L8, Canada
[7] McMaster Univ, Hamilton, ON L8S 4L8, Canada
关键词
acute lymphoblastic leukemia; adolescents and young adult; protocol; pediatric-inspired; survival; BERLIN-FRANKFURT-MUNSTER; HYPER-CVAD; CHEMOTHERAPY; PROTOCOL; TOXICITY; SURVIVAL; THERAPY;
D O I
10.3390/curroncol30090625
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL) have significantly worse outcomes than their younger counterparts. Current treatment guidelines rely mostly on non-randomized retrospective studies. We performed a systematic review of studies published within the last 15 years comparing pediatric-inspired regimens (PIR) versus adult-type regimens or performing an age-stratified analysis of outcomes in the AYA population. Due to the heterogeneity of data, a meta-analysis was not possible. However, the gathered data show a trend toward improvement in outcomes and an acceptable toxicity profile in patients treated with PIRs compared to conventional adult-type regimens. There is still room for further improvement, as older patients within the AYA population tend to perform poorly with PIR or conventional adult-type chemotherapy. Further randomized studies are needed to develop an optimal treatment strategy for AYA with ALL.
引用
收藏
页码:8612 / 8632
页数:21
相关论文
共 35 条
[1]   Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia [J].
Advani, Anjali S. ;
Larsen, Eric ;
Laumann, Kristina ;
Luger, Selina M. ;
Liedtke, Michaela ;
Devidas, Meenakshi ;
Chen, Zhiguo ;
Yin, Jun ;
Foster, Matthew C. ;
Claxton, David ;
Coffan, Kristin ;
Tallman, Martin S. ;
Appelbaum, Frederick R. ;
Erba, Harry ;
Stone, Richard M. ;
Hunger, Stephen P. ;
McNeer, Jennifer L. ;
Loh, Mignon L. ;
Raetz, Elizabeth ;
Winick, Naomi ;
Carroll, William ;
Larson, Richard A. ;
Stock, Wendy .
BLOOD ADVANCES, 2021, 5 (02) :504-512
[2]   Improved survival using an intensive, pediatric-based chemotherapy regimen in adults with T-cell acute lymphoblastic leukemia [J].
Al-Khabori, Murtadha ;
Minden, Mark D. ;
Yee, Karen W. L. ;
Gupta, Vikas ;
Schimmer, Aaron D. ;
Schuh, Andre C. ;
Xu, Wei ;
Brandwein, Joseph M. .
LEUKEMIA & LYMPHOMA, 2010, 51 (01) :61-65
[3]   Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers [J].
Alacacioglu, Inci ;
Medeni, Serife S. ;
Ozsan, Guner H. ;
Payzin, Bahriye ;
Sevindik, O. Gokmen ;
Acar, Celal ;
Katgi, Abdullah ;
Ozdemirkan, Fusun ;
Piskin, Ozden ;
Ozcan, Mehmet A. ;
Undar, Bulent ;
Demirkan, Fatih .
CHEMOTHERAPY, 2014, 60 (04) :219-223
[4]   Comparison of Two Pediatric-Inspired Regimens to Hyper-CVAD in Hispanic Adolescents and Young Adults With Acute Lymphoblastic Leukemia [J].
Almanza-Huante, Emmanuel ;
Espinosa-Bautista, Karla ;
Rangel-Patino, Juan ;
Demichelis-Gomez, Roberta .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (01) :55-+
[5]   Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children? [J].
Boissel, Nicolas ;
Baruchel, Andre .
BLOOD, 2018, 132 (04) :351-361
[6]   Predictors of outcome in adults with BCR-ABL negative acute lymphoblastic leukemia treated with a pediatric-based regimen [J].
Brandwein, Joseph M. ;
Atenafu, Eshetu G. ;
Schuh, Andre C. ;
Yee, Karen W. L. ;
Schimmer, Aaron D. ;
Gupta, Vikas ;
Minden, Mark D. .
LEUKEMIA RESEARCH, 2014, 38 (05) :532-536
[7]   Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232 [J].
Burke, Michael J. ;
Devidas, Meenakshi ;
Chen, Zhiguo ;
Salzer, Wanda L. ;
Raetz, Elizabeth A. ;
Rabin, Karen R. ;
Heerema, Nyla A. ;
Carroll, Andrew J. ;
Gastier-Foster, Julie M. ;
Borowitz, Michael J. ;
Wood, Brent L. ;
Winick, Naomi J. ;
Carroll, William L. ;
Hunger, Stephen P. ;
Loh, Mignon L. ;
Larsen, Eric C. .
LEUKEMIA, 2022, 36 (03) :648-655
[8]   Outcome of young adult patients with very-high-risk acute lymphoblastic leukemia treated with pediatric-type chemotherapy- a single institute experience [J].
Cheng, Chao-Neng ;
Li, Sin-Syue ;
Hsu, Ya-Ting ;
Chen, Ya-Ping ;
Chen, Tsai-Yun ;
Chen, Jiann-Shiuh .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (03) :694-702
[9]   Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia [J].
DeAngelo, D. J. ;
Stevenson, K. E. ;
Dahlberg, S. E. ;
Silverman, L. B. ;
Couban, S. ;
Supko, J. G. ;
Amrein, P. C. ;
Ballen, K. K. ;
Seftel, M. D. ;
Turner, A. R. ;
Leber, B. ;
Howson-Jan, K. ;
Kelly, K. ;
Cohen, S. ;
Matthews, J. H. ;
Savoie, L. ;
Wadleigh, M. ;
Sirulnik, L. A. ;
Galinsky, I. ;
Neuberg, D. S. ;
Sallan, S. E. ;
Stone, R. M. .
LEUKEMIA, 2015, 29 (03) :526-534
[10]   Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE) [J].
Ferrari, A. ;
Stark, D. ;
Peccatori, F. A. ;
Fern, L. ;
Laurence, V ;
Gaspar, N. ;
Bozovic-Spasojevic, I ;
Smith, O. ;
De Munter, J. ;
Derwich, K. ;
Hjorth, L. ;
van der Graaf, W. T. A. ;
Soanes, L. ;
Jezdic, S. ;
Blondeel, A. ;
Bielack, S. ;
Douillard, J-Y ;
Mountzios, G. ;
Saloustros, E. .
ESMO OPEN, 2021, 6 (02)